GB2359749A - Anti-asthmatic combinations comprising surface active phospholipids - Google Patents

Anti-asthmatic combinations comprising surface active phospholipids

Info

Publication number
GB2359749A
GB2359749A GB0114529A GB0114529A GB2359749A GB 2359749 A GB2359749 A GB 2359749A GB 0114529 A GB0114529 A GB 0114529A GB 0114529 A GB0114529 A GB 0114529A GB 2359749 A GB2359749 A GB 2359749A
Authority
GB
United Kingdom
Prior art keywords
asthmatic
combinations
surface active
active phospholipids
phospholipids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB0114529A
Other versions
GB2359749B (en
GB0114529D0 (en
Inventor
Brian Andrew Hills
Derek Alan Woodcock
John Nicholas Staniforth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Britannia Pharmaceuticals Ltd
Original Assignee
Britannia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB1998/003543 external-priority patent/WO1999027920A2/en
Priority claimed from GBGB9912639.3A external-priority patent/GB9912639D0/en
Application filed by Britannia Pharmaceuticals Ltd filed Critical Britannia Pharmaceuticals Ltd
Publication of GB0114529D0 publication Critical patent/GB0114529D0/en
Publication of GB2359749A publication Critical patent/GB2359749A/en
Application granted granted Critical
Publication of GB2359749B publication Critical patent/GB2359749B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder
GB0114529A 1998-11-26 1999-11-26 Anti-asthmatic combinations comprising surface active phospholipids Expired - Fee Related GB2359749B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/GB1998/003543 WO1999027920A2 (en) 1997-12-03 1998-11-26 Use of phospholipids for the manufacture of a medicament for the treatment of asthma
GBGB9912639.3A GB9912639D0 (en) 1999-05-28 1999-05-28 Improvements in and relating to treatment of respiratory conditions
PCT/GB1999/003952 WO2000030654A1 (en) 1998-11-26 1999-11-26 Anti-asthmatic combinations comprising surface active phospholipids

Publications (3)

Publication Number Publication Date
GB0114529D0 GB0114529D0 (en) 2001-08-08
GB2359749A true GB2359749A (en) 2001-09-05
GB2359749B GB2359749B (en) 2004-05-05

Family

ID=26313152

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0114529A Expired - Fee Related GB2359749B (en) 1998-11-26 1999-11-26 Anti-asthmatic combinations comprising surface active phospholipids

Country Status (4)

Country Link
EP (1) EP1133301A1 (en)
JP (2) JP3840515B2 (en)
GB (1) GB2359749B (en)
WO (1) WO2000030654A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9912639D0 (en) 1999-05-28 1999-07-28 Britannia Pharmaceuticals Ltd Improvements in and relating to treatment of respiratory conditions
WO2002094283A2 (en) * 2001-05-21 2002-11-28 Britannia Pharmaceuticals Limited Use of phospholipids in the treatment of degenerative lung disease such as copd or cystic fibrosis and to enhance delivery of drugs
TWI324934B (en) * 2001-08-28 2010-05-21 Schering Corp Pharmaceutical compositions for the treatment of asthma
WO2004018025A1 (en) * 2002-08-23 2004-03-04 Schering Corporation Pharmaceutical compositions
AU2004257375A1 (en) * 2003-07-21 2005-01-27 Vasogen Ireland Limited Liposomes containing phosphate glycerol groups for treating acute inflammatory condition
GB0426010D0 (en) * 2004-11-26 2004-12-29 Britannia Pharmaceuticals Ltd Improvements in or relating to organic materials
KR100891595B1 (en) 2005-02-28 2009-04-03 주식회사 케이티앤지 Composition for reducing the exudation of serum proteins
GB0510463D0 (en) * 2005-05-23 2005-06-29 Britania Pharmaceuticals Ltd Improvements in or relating to organic materials

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991016882A1 (en) * 1990-05-08 1991-11-14 Liposome Technology, Inc. Direct spray-dried drug/lipid powder composition
EP0528034A1 (en) * 1990-05-18 1993-02-24 Tokyo Tanabe Company Limited Remedy for asthma
WO1996019199A1 (en) * 1994-12-22 1996-06-27 Astra Aktiebolag Proliposome powders for inhalation
WO1996022764A1 (en) * 1995-01-24 1996-08-01 Novartis Ag Liposomes containing a corticosteroid
WO1999027920A2 (en) * 1997-12-03 1999-06-10 Britannia Pharmaceuticals Limited Use of phospholipids for the manufacture of a medicament for the treatment of asthma

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991016882A1 (en) * 1990-05-08 1991-11-14 Liposome Technology, Inc. Direct spray-dried drug/lipid powder composition
EP0528034A1 (en) * 1990-05-18 1993-02-24 Tokyo Tanabe Company Limited Remedy for asthma
WO1996019199A1 (en) * 1994-12-22 1996-06-27 Astra Aktiebolag Proliposome powders for inhalation
WO1996022764A1 (en) * 1995-01-24 1996-08-01 Novartis Ag Liposomes containing a corticosteroid
WO1999027920A2 (en) * 1997-12-03 1999-06-10 Britannia Pharmaceuticals Limited Use of phospholipids for the manufacture of a medicament for the treatment of asthma

Also Published As

Publication number Publication date
GB2359749B (en) 2004-05-05
GB0114529D0 (en) 2001-08-08
EP1133301A1 (en) 2001-09-19
JP2002530344A (en) 2002-09-17
JP2006199713A (en) 2006-08-03
JP3840515B2 (en) 2006-11-01
WO2000030654A1 (en) 2000-06-02

Similar Documents

Publication Publication Date Title
IL141823A0 (en) Glyphosate formulation
AU1287800A (en) Anti-asthmatic combinations comprising surface active phospholipids
IL131358A0 (en) Surfactants
GB2359749B (en) Anti-asthmatic combinations comprising surface active phospholipids
AU3004799A (en) Surface active polyesters
GB9825781D0 (en) Surface appearance-improving agent
PL324740A1 (en) Cube surface
GB2327585B (en) Surface construction
GB2343856B (en) Surface finishing covalent-lonic ceramics
GB9825041D0 (en) Rough surface wafer
HU9802698D0 (en) Surface cutter
GB9704874D0 (en) Surface removal
AU138132S (en) Flat surface joiner
GB9820866D0 (en) Wipe packs
GB9810196D0 (en) Surface cleaner
GB9702621D0 (en) Surface cleaner
GB9707112D0 (en) Variant surface level-identification system
GB9914848D0 (en) Shape conforming surface
AU136951S (en) Gameboard
GB9801868D0 (en) Surfactants
HUP9903212A3 (en) Branched surfactant manufacture
GB9816932D0 (en) Playing surface
TW319051U (en) Cup structure having tea-filtering function
AU136313S (en) Four way powerboard
AU136316S (en) Four way powerboard

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20111126